Cita APA

C, T., M, M., A, A., J, A., AV, R., E, C., . . . A, H. (2016). Evidence for Tocilizumab as a Treatment Option in Refractory Uveitis Associated with Juvenile Idiopathic Arthritis.

Citación estilo Chicago

C, Tappeiner, et al. Evidence for Tocilizumab As a Treatment Option in Refractory Uveitis Associated With Juvenile Idiopathic Arthritis. 2016.

Cita MLA

C, Tappeiner, et al. Evidence for Tocilizumab As a Treatment Option in Refractory Uveitis Associated With Juvenile Idiopathic Arthritis. 2016.